Related Experiment Video

Updated: May 23, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

BRCA1-IRIS overexpression promotes formation of aggressive breast cancers

Yoshiko Shimizu1, Hugh Luk, David Horio

  • 1Cancer Institute and Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi, United States of America.

Plos One
|April 19, 2012
PubMed
Abstract

Insights

BRCA1-IRIS overexpression drives aggressive HER2(+) and triple-negative/basal-like breast cancers. Targeting BRCA1-IRIS may offer a new therapeutic strategy for these difficult-to-treat tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • HER2(+) and triple-negative/basal-like (TN/BL) breast cancers have poor prognoses due to treatment resistance and lack of targeted therapies.
  • BRCA1-IRIS, an alternative product of the BRCA1 gene, exhibits oncoprotein-like properties and is implicated in tumor development.

Purpose of the Study:

  • To investigate BRCA1-IRIS as a potential therapeutic target in HER2(+) and TN/BL breast cancers.
  • To analyze the correlation between BRCA1-IRIS expression and key cancer markers and clinical parameters.

Main Methods:

  • Immunohistochemical staining of human breast tumor samples to assess BRCA1-IRIS expression and its correlation with AKT1, AKT2, p-AKT, survivin, and BRCA1/p220.
  • In vivo studies using SCID mice with human mammary epithelial cells overexpressing BRCA1-IRIS to evaluate tumor formation and characteristics.
  • Induction of mammary tumors in rats using N-methyl-N-nitrosourea (NMU) to analyze BRCA1-IRIS and ERα mRNA levels.

Main Results:

  • High BRCA1-IRIS expression was prevalent in human breast tumors, correlating positively with AKT1, AKT2, p-AKT, and survivin, and negatively with BRCA1/p220.
  • BRCA1-IRIS positivity was associated with high-grade, early-onset, and metastatic HER2(+) or TN/BL tumors.
  • Overexpression of BRCA1-IRIS in HME cells led to invasive tumors with aggressive molecular profiles, while NMU-induced rat tumors showed high BRCA1-IRIS and low ERα mRNA.

Conclusions:

  • BRCA1-IRIS overexpression is a driver of aggressive breast tumor formation, particularly in HER2(+) and TN/BL subtypes.
  • Inhibition of BRCA1-IRIS presents a promising novel therapeutic strategy for these aggressive breast cancer subtypes.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...